Preclinical testing of new vaccines for tuberculosis: a comprehensive review.
about
Co-administration of IL-1+IL-6+TNF-α with Mycobacterium tuberculosis infected macrophages vaccine induces better protective T cell memory than BCGProphylactic effect of a therapeutic vaccine against TB based on fragments of Mycobacterium tuberculosisProtective efficacy of BCG overexpressing an L,D-transpeptidase against M. tuberculosis infection.Phenotypic definition of effector and memory T-lymphocyte subsets in mice chronically infected with Mycobacterium tuberculosis.T cell reactivity against mycolyl transferase antigen 85 of M. tuberculosis in HIV-TB coinfected subjects and in AIDS patients suffering from tuberculosis and nontuberculous mycobacterial infections.Torticollis in mice intravenously infected with Mycobacterium tuberculosis.Differential Mycobacterium bovis BCG vaccine-derived efficacy in C3Heb/FeJ and C3H/HeOuJ mice exposed to a clinical strain of Mycobacterium tuberculosis.Whole genome response in guinea pigs infected with the high virulence strain Mycobacterium tuberculosis TT372Development of new vaccines and drugs for TB: limitations and potential strategic errorsESAT-6 (EsxA) and TB10.4 (EsxH) based vaccines for pre- and post-exposure tuberculosis vaccination.Post-exposure vaccination against Mycobacterium tuberculosis.Characterization of two in vivo-expressed methyltransferases of the Mycobacterium tuberculosis complex: antigenicity and genetic regulation.Increased Foxp3 expression in guinea pigs infected with W-Beijing strains of M. tuberculosisVaccination of guinea pigs using mce operon mutants of Mycobacterium tuberculosis.The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infectionA recombinant Mycobacterium smegmatis induces potent bactericidal immunity against Mycobacterium tuberculosis.Animal models of tuberculosis: Guinea pigs.Live attenuated Salmonella vaccines against Mycobacterium tuberculosis with antigen delivery via the type III secretion system.Extended safety and efficacy studies of the attenuated Brucella vaccine candidates 16 M(Delta)vjbR and S19(Delta)vjbR in the immunocompromised IRF-1-/- mouse model.A Higher Activation Threshold of Memory CD8+ T Cells Has a Fitness Cost That Is Modified by TCR Affinity during TuberculosisA mutant of Mycobacterium tuberculosis lacking the 19-kDa lipoprotein Rv3763 is highly attenuated in vivo but retains potent vaccinogenic properties.Tuberculosis vaccines: current status and future prospects.Influence of Mycobacterium bovis BCG vaccination on cellular immune response of guinea pigs challenged with Mycobacterium tuberculosis.Protective efficacy of a recombinant BCG secreting antigen 85B/Rv3425 fusion protein against Mycobacterium tuberculosis infection in mice.DNA vaccines against mycobacterial diseases.The guinea pig as a model of infectious diseases.MUC1-based recombinant Bacillus Calmette-Guerin vaccines as candidates for breast cancer immunotherapy.DNA vaccines for targeting bacterial infections.Tuberculosis vaccines in clinical trials.Time to detection of Mycobacterium tuberculosis using the MGIT 320 system correlates with colony counting in preclinical testing of new vaccines.PPE57 induces activation of macrophages and drives Th1-type immune responses through TLR2.Prime-boost bacillus Calmette-Guérin vaccination with lentivirus-vectored and DNA-based vaccines expressing antigens Ag85B and Rv3425 improves protective efficacy against Mycobacterium tuberculosis in mice.A Nonsynonymous SNP Catalog of Mycobacterium tuberculosis Virulence Genes and Its Use for Detecting New Potentially Virulent SublineagesA Toll-like receptor-2-directed fusion protein vaccine against tuberculosis.Adjuvants induce distinct immunological phenotypes in a bovine tuberculosis vaccine model.Cell proliferation and interferon-gamma response to recombinant MBP-3, NarL, MT-10.3, and 16 kDa Mycobacterium tuberculosis antigens in Brazilian tuberculosis patients.Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost?Trying to See the Forest through the Trees: Deciphering the Nature of Memory Immunity to Mycobacterium tuberculosis.Live tuberculosis vaccines based onphoPmutants: a step towards clinical trials
P2860
Q27437712-741631C2-8B28-40B4-B462-BFD176EC5FD1Q28744312-77FF34B0-E40A-441E-8886-EC1E45CC4F77Q33737428-50EF77BC-3C1C-4A1A-871B-3F197F9E2DAEQ33768651-796DD6E0-6189-40A0-9D40-474DA8392C22Q34169888-DA14FF55-0708-4C4F-A046-24605870AD26Q34701378-7B0E3673-8104-41F0-829B-BC910C415C77Q34784945-7E1B0955-1B12-4DEF-B981-3D76A534BFF8Q35042642-279F7102-19D8-4381-93C0-A14632AD6EDAQ35065531-5E95C04D-CEA5-40CF-BF93-D81F934BF365Q35069386-DBF5E9E1-A148-4CAD-A0FC-1F27C9C0A80EQ35101154-8CD25208-12B5-4E33-AD71-292C771E327EQ35132263-5E65F7F0-B637-42CA-B54F-5A23C413786CQ35211139-2C737E22-6E68-4330-906D-041B3D214638Q35220322-60F5E4C1-781A-4E3A-A4A8-41CBABFDBC00Q35640563-0C40875E-13B6-4145-ABA2-4350E20F60F2Q35647253-2D7A35B3-E0A6-4E59-9C33-069E2691CA2DQ35663870-5F3F9DCB-8B9E-4297-A303-0A2621128EFEQ35689514-E8C321CF-8B4F-4DA8-B7AF-6F6913079A2DQ35739119-2DD72271-03CD-4C4F-9531-B55F10319E47Q35888761-E3D25BB7-64E4-4A77-AF2E-050D02594670Q36334430-07EBEDFB-789B-4D54-BAC0-640DC73974AAQ36458393-FCB7E3E6-435B-4F85-927E-3C4FB028128DQ36844929-24D9EA8B-48EF-40F2-95AE-E9B5277AD794Q36849823-A0CA5A55-08BB-43A0-9DB0-E82548C310CEQ36895737-E8C61AFB-4A6A-476B-B299-CE01B7B81463Q37251175-A60E2666-2145-488A-94D7-BEDD7C09F802Q37737313-79B75ADB-3B10-4DC9-BDEC-39548D645CE3Q37771943-D641D74F-FE99-4754-BCCB-182814FA29FEQ37878483-CD2B3A33-2D9E-41CF-937F-64CE84290705Q38320793-8A3879C1-0045-49DE-90C6-C276AA4AA256Q38920325-E26B94C3-E1CE-4791-9A77-0648B97DB920Q39202380-47018778-A1FF-4611-9349-81532062626AQ42146154-FEDA2C7E-8808-4392-9CC5-FBDC8F252906Q42413220-B0F0D60A-9243-4989-ADB1-EA53B5F568EEQ42576378-22E0CBD6-4050-4DA6-873E-FA27531283D9Q44281994-4F944568-7849-41AD-88EA-DE0114B44734Q47834561-F65AF36F-2AF1-4C11-865B-0DC14D554F2AQ52641618-8D5B9D00-1C93-45BD-97D1-C5F4DCD32851Q58834940-4F081EE9-569D-474D-9399-45B22BA8F898
P2860
Preclinical testing of new vaccines for tuberculosis: a comprehensive review.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Preclinical testing of new vaccines for tuberculosis: a comprehensive review.
@ast
Preclinical testing of new vaccines for tuberculosis: a comprehensive review.
@en
type
label
Preclinical testing of new vaccines for tuberculosis: a comprehensive review.
@ast
Preclinical testing of new vaccines for tuberculosis: a comprehensive review.
@en
prefLabel
Preclinical testing of new vaccines for tuberculosis: a comprehensive review.
@ast
Preclinical testing of new vaccines for tuberculosis: a comprehensive review.
@en
P1433
P1476
Preclinical testing of new vaccines for tuberculosis: a comprehensive review.
@en
P2093
Ian M Orme
P356
10.1016/J.VACCINE.2005.07.078
P407
P577
2005-08-08T00:00:00Z